Divisions of Cardiac Surgery and Cardiology, Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Am J Cardiol. 2012 Dec 1;110(11):1667-78. doi: 10.1016/j.amjcard.2012.07.041. Epub 2012 Aug 23.
Limited data have suggested that an "obesity paradox" exists for mortality and cardiovascular outcomes in patients undergoing coronary artery bypass grafting. Much less is known about the role of the preoperative body mass index (BMI) in patients undergoing valve surgery. We evaluated 2,640 consecutive patients who underwent valve surgery between April 2004 and March 2011. The patients were classified by the World Health Organization standards as "underweight" (BMI 11.5 to 18.4 kg/m(2), n = 61), "normal weight" (BMI 18.5 to 24.9 kg/m(2), n = 865), "overweight" (BMI 25 to 29.9 kg/m(2), n = 1,020), and "obese" (BMI 30 to 60.5 kg/m(2), n = 694). Mortality was ascertained using the Social Security Death Index. Hazard ratios (HRs), adjusted for known preoperative risk factors, were obtained using Cox regression models. The mean follow-up was 31.9 ± 20.5 months. The long-term mortality rate was 1.21, 0.52, 0.32, and 0.44 per 10 years of person-time for underweight, normal, overweight, and obese patients, respectively. Compared to the normal BMI category, overweight patients (adjusted HR 0.60, 95% confidence interval 0.46 to 0.79, p <0.001) and obese patients (adjusted HR 0.67, 95% confidence interval 0.50 to 0.91, p = 0.009) were at a lower hazard of long-term all-cause mortality. Underweight patients remained at a greater adjusted risk of long-term mortality than normal weight patients (adjusted HR 1.69, 95% confidence interval 1.01 to 2.85, p = 0.048). Similar patterns of mortality outcomes were noted in the subset of patients undergoing isolated valve surgery. In conclusion, overweight and obese patients had greater survival after valve surgery than patients with a normal BMI. Very lean patients undergoing valve surgery are at a greater hazard for mortality and might require more rigorous preoperative candidate screening and closer postoperative monitoring.
有限的数据表明,在接受冠状动脉旁路移植术的患者中,死亡率和心血管结局存在“肥胖悖论”。关于术前体重指数(BMI)在接受瓣膜手术的患者中的作用,人们知之甚少。我们评估了 2640 名连续接受瓣膜手术的患者,这些患者于 2004 年 4 月至 2011 年 3 月期间接受手术。根据世界卫生组织标准,患者被分为“消瘦”(BMI 为 11.5 至 18.4kg/m2,n=61)、“正常体重”(BMI 为 18.5 至 24.9kg/m2,n=865)、“超重”(BMI 为 25 至 29.9kg/m2,n=1020)和“肥胖”(BMI 为 30 至 60.5kg/m2,n=694)。使用社会安全死亡索引确定死亡率。使用 Cox 回归模型获得调整已知术前危险因素后的风险比(HR)。平均随访时间为 31.9±20.5 个月。消瘦、正常体重、超重和肥胖患者的 10 年预期死亡率分别为每 10 年 1.21、0.52、0.32 和 0.44。与正常 BMI 组相比,超重患者(调整后的 HR 0.60,95%置信区间 0.46 至 0.79,p<0.001)和肥胖患者(调整后的 HR 0.67,95%置信区间 0.50 至 0.91,p=0.009)的长期全因死亡率较低。消瘦患者的长期死亡率调整后风险仍高于正常体重患者(调整后的 HR 1.69,95%置信区间 1.01 至 2.85,p=0.048)。在接受单纯瓣膜手术的患者亚组中,也观察到了类似的死亡结局模式。总之,与 BMI 正常的患者相比,超重和肥胖患者在接受瓣膜手术后的生存率更高。接受瓣膜手术的非常消瘦患者的死亡率风险更高,可能需要更严格的术前候选者筛选和更密切的术后监测。